Hyung Heon Kim - Aug 11, 2024 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role
CEO & President, Director
Signature
/s/ Phillip D. Torrence, by Power of Attorney
Stock symbol
NRBO
Transactions as of
Aug 11, 2024
Transactions value $
-$41,281
Form type
4
Date filed
8/13/2024, 04:01 PM
Previous filing
Aug 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRBO Common Stock Tax liability -$41.3K -11.5K -14.68% $3.60 66.7K Aug 11, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Issuer in satisfaction of the Reporting Person's tax liabilities in connection with the vesting of restricted stock units, based on the Issuer's closing price on August 9, 2024.
F2 The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023.